Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.
Endothelial cells are the key components of vascular intima and play pivotal roles in vasculogenesis, angiogenesis, and tumor growth. Using Northern blot and real-time PCR, we confirmed that miR-126 and its host gene EGF-like domain 7 (EGFL7) were widely expressed in rat tissues but strictly expressed in endothelial cells. In mammals, miR-126 gene is embedded in intron7 of EGFL7. To explore the biogenesis of miR-126, plasmid EGFL7(126)-pEGFPc1 containing segment of exon7-intron7-exon8 of EGFL7 was constructed and expressed in 293T. Expression of spliced exon7-8 and excised mature miR-126 was detected by PCR and Northern blot. Knocking-down of endothelial endogenous miR-126 did not affect EGFL7 expression at mRNA or protein level. To investigate the possible roles of miR-126, PicTar, miRBase, miRanda, Bibiserv, and Targetscan were used to screen the targets. VEGFA and PIK3R2 were confirmed as the targets of miR-126 by luciferase reporter assay and Western blot. Interestingly, Northern blot and western blot showed that miR-126 was down-regulated in breast tumors where the VEGF/PI3K/AKT signaling pathway was activated. Introduction of miR-126 mimics into MCF-7 could effectively decrease VEGF/PI3K/AKT signaling activity. In summary, miR-126 was strictly expressed in endothelial cells and excised from EGFL7 pre-mRNA without affecting splicing and expression of its host gene. In addition, miR-126 could target both VEGFA and PIK3R2, and its expression was decreased in human breast cancer, implying that miR-126 may play a role in tumor genesis and growth by regulating the VEGF/PI3K/AKT signaling pathway.
Department of Cardiology, Changhai Hospital, 168 Changhai Road, Shanghai 200433, People's Republic of China.
Ni
N
Zhu
Dongze
D
Zhang
Haoping
H
Xie
Zhe
Z
Zhou
Huyan
H
Chen
Tiantian
T
Hu
Yuan
Y
Bai
Yuan
Y
Shen
Wenjun
W
Yuan
Qing
Q
Jing
Yongwen
Y
Qin
D000818:Animals; D001483:Base Sequence; D001943:Breast Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D002478:Cells, Cultured; D017931:DNA Primers; D015536:Down-Regulation; D004730:Endothelium, Vascular / Q000378:metabolism*; D005260:Female; D006801:Humans; D007438:Introns; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D017931:DNA Primers; C527111:MIRN126 microRNA, human; D035683:MicroRNAs; D042461:Vascular Endothelial Growth Factor A; D019869:Phosphatidylinositol 3-Kinases; C560566:phosphoinositol-3 kinase regulatory subunit 2, human
Apoptosis. 2000 Oct;5(4):323-8
11227213
PLoS One. 2009;4(4):e5052
19337377
Curr Biol. 2002 Apr 30;12(9):735-9
12007417
Dev Dyn. 2008 Mar;237(3):580-91
18224713
Nat Rev Mol Cell Biol. 2008 Mar;9(3):219-30
18270516
Nat Rev Cancer. 2006 Apr;6(4):259-69
16557279
Nature. 2005 Jul 14;436(7048):214-20
15951802
Dev Cell. 2008 Aug;15(2):272-84
18694566
Nature. 2008 Jan 10;451(7175):147-52
18185580
Am J Pathol. 2005 Jul;167(1):275-84
15972971
Nat Genet. 2006 Feb;38(2):228-33
16380711
Nat Med. 2003 Jun;9(6):653-60
12778163
Circ Res. 2000 Jan 7-21;86(1):4-5
10625297
Nature. 2007 Jul 5;448(7149):83-6
17589500
Dev Dyn. 2004 Jun;230(2):316-24
15162510
Nature. 2005 Dec 15;438(7070):937-45
16355211
Cell Stem Cell. 2008 Mar 6;2(3):219-29
18371447
FASEB J. 2010 Sep;24(9):3255-63
20439489
EMBO J. 2003 Nov 3;22(21):5700-11
14592969
Lab Invest. 2000 Jan;80(1):99-115
10653008
Dev Cell. 2008 Aug;15(2):261-71
18694565
Nat Med. 2003 Jun;9(6):661-8
12778164
PLoS One. 2009;4(5):e5605
19440384
Nature. 2000 Sep 14;407(6801):242-8
11001067
Cell. 2009 Jan 23;136(2):215-33
19167326
Nature. 2004 Apr 15;428(6984):754-8
15085134
Cell. 2004 Jan 23;116(2):281-97
14744438
Nature. 2000 Sep 14;407(6801):249-57
11001068
Cell. 2007 Aug 24;130(4):691-703
17719546